NIAID’s Single-Photon Emission Computed Tomography

NIAID’s Single-Photon Emission Computed Tomography

Agency: 
Dept. of Health and Human Services

Primates Research NIAID

Findings from a National Institute of Allergy and Infectious Diseases (NIAID) animal study suggest that a noninvasive imaging technique could, with further development, become a useful tool to assess immune system recovery in people receiving treatment for HIV infection. NIAID researchers used single-photon emission computed tomography (SPECT) and an CD4-specific imaging probe to assess immune system changes throughout macaques infected with SIV, a simian form of HIV, following initiation and interruption of antiretroviral therapy (ART). In the future, extension of this imaging technology to humans may aid scientists in evaluating immune reconstitution following standard and experimental HIV treatments.

The Division of Clinical Research (DCR) plays an integral role in facilitating the performance of NIAID research programs on domestic and international levels. This is accomplished through a multifaceted approach to the services vital to the research infrastructure that includes oversight and management of intramural clinical research, program planning and management, regulatory monitoring and compliance, statistical consultation, and research methodology.

To learn more about NIAID, visit its laboratory profile on FLC Business.

Category: 
Lab Spotlight
Region: 
Mid-Atlantic